Navigation Links
Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
Date:10/13/2009

EVRY, October 13 /PRNewswire/ -- Philippe Marliere, cofounder and initiator of the project, has announced the establishment of the scientific advisory board:

    - Dr. Bernard Badet heads a research group at the Institut de
      Chimie des Substances Naturelles (Gif-sur-Yvette, France) that is
      interested in the understanding of the enzyme mechanism towards the
      development of chemical tools for diagnostic and therapeutic purposes.

    - Prof. Donald Hilvert heads a research group at the ETH
      Zurich (Zurich, Switzerland). His research program focuses on
      understanding how enzymes work and evolve and on mimicking the
      properties of these remarkable catalysts in the laboratory.

    - Prof. Jean-Marc Paris led the R&D division responsible for
      antibiotic discovery at Rhone Poulenc Rorer before joining Rhodia,
      where he worked as Scientific Director for organic chemistry and
      biotechnologies. He is honorary Professor at the Ecole Nationale
      Superieure de Chimie de Paris.

    - Prof. Dieter Soll heads a research laboratory at Yale
      University in New Haven (Connecticut, USA), investigating the
      biocatalytic and evolutionary basis of protein biosynthesis. Prof. Soll
      is a member of the US Academy of Sciences.

    - Dr. Jean Weissenbach is the Director of Genoscope, the
      French genome sequencing center, which he founded in 1997. Now part of
      the Genomics Institute of the CEA, Genoscope is searching new enzyme
      activities using genomics and large scale experimentation. Dr.
      Weissenbach is a member of the French Academy of Sciences.

Global Bioenergies, located on the Genopole campus close to Paris, has today announced the proof-of-concept of a synthetic metabolic pathway for producing isobutene, a key building block that can be converted into transportation fuels, polymers and various commodity chemicals.

Macha Anissimova, Head of Research, said "We are very proud to have reached this key milestone in advance on schedule. We have benefited from the assistance of Genoscope and of the analytical chemistry platform of Evry-Val d'Essonne University. The bioproduction of a gaseous hydrocarbon will make it possible to obtain pure products at high yield and low cost.".

According to Prof. Dieter Soll, "The data on isobutene formation presented by Global Bioenergies are convincing, and I am now impatient to see the process optimized and scaled up."

"Development of such an artificial metabolic pathway represents a signal accomplishment with enormous implications. Standard technologies for enzyme and metabolic engineering can now be applied to transform this proof of concept into a viable industrial process," added Prof. Donald Hilvert.

Marc Delcourt, cofounder and CEO of the company concludes: "We are now focusing on industrializing the process, which will be financed through a second round currently in preparation."

Please visit our new web site: http://www.global-bioenergies.com

SOURCE Global Bioenergies


'/>"/>
SOURCE Global Bioenergies
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
2. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
3. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
4. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
5. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
6. Global Biofuels Growth to Double by 2015
7. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
8. Global Public Health the Focus of Scientific Conference
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
11. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... EDISON, N.J. , Feb. 4, 2016 ... company focused on the development and commercialization of targeted ... BIO CEO & Investor Conference 2016, to be held ... and Source Capital Group,s 2016 Disruptive Growth & Healthcare ... on February 10-11, 2016. James Sapirstein ...
(Date:2/4/2016)... , February 4, 2016 ... Laboratories (ABL), Inc. --> Strasbourg, France ... --> PharmaVentures is pleased to announce that it ... its biopharmaceutical manufacturing unit in Strasbourg, France ... --> --> Transgene (Euronext: ...
(Date:2/3/2016)... -- With the growing need for better therapeutics, and ... such as monoclonal antibodies, recombinant protein therapeutics and ... are in high demand. Conventionally expression systems were ... of these therapeutics. However, due to issues with ... approaches and novel expression systems are currently being ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... a new office dedicated to the North American healthcare market. , Aerocom Healthcare, ... healthcare facilities. The company will provide new pneumatic tube systems or expand ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
Breaking Biology News(10 mins):